40th week of 2020 patent applcation highlights part 29 |
Patent application number | Title | Published |
20200308135 | LXR INVERSE AGONISTS FOR TREATMENT OF CANCER | 2020-10-01 |
20200308136 | CRYSTALS OF TETRAHYDRONAPHTHYL UREA DERIVATIVE | 2020-10-01 |
20200308137 | Pyrazine-4-Carbamate or -Urea Derivatives As Herbicides | 2020-10-01 |
20200308138 | METHOD FOR PREPARING 1,1'-ETHYLENE-2,2'-BIPYRIDINIUM DICHLORIDE | 2020-10-01 |
20200308139 | OXOPIPERAZINE DERIVATIVES | 2020-10-01 |
20200308140 | SUBSTITUTED QUINAZOLINE COMPOUND HAVING BLOOD-BRAIN BARRIER PENETRATION CAPABILITY | 2020-10-01 |
20200308141 | SOLID STATE FORMS OF NERATINIB AND SALTS THEREOF | 2020-10-01 |
20200308142 | Substituted Pyrazole Derivatives As Selective CDK12/13 Inhibitors | 2020-10-01 |
20200308143 | SYNTHESIS OF OMECAMTIV MECARBIL | 2020-10-01 |
20200308144 | Multimeric piperidine derivatives | 2020-10-01 |
20200308145 | BENZIMIDAZOLE DERIVATIVES AND THEIR USES | 2020-10-01 |
20200308146 | SOLID STATE FORMS OF IVOSIDENIB | 2020-10-01 |
20200308147 | NOVEL DEUTERATED COMPOUNDS AS INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND/OR AS BCL6 DEGRADERS | 2020-10-01 |
20200308148 | PYRAZOLE O-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | 2020-10-01 |
20200308149 | FUSED AND CROSS-LINKABLE IONIC HOLE TRANSPORT MATERIALS FOR PEROVSKITE SOLAR CELLS | 2020-10-01 |
20200308150 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 2020-10-01 |
20200308151 | METHOD FOR PREPARING OXASPIROCYCLE DERIVATIVE, AND INTERMEDIATE THEREOF | 2020-10-01 |
20200308152 | PROCESS FOR THE PREPARATION OF 2-(5-METHOXYISOCHROMAN-1 -YL)-4,5-DIHYDRO-1 H-IMIDAZOLE AND THE HYDROGENSULFATE SALT THEREOF | 2020-10-01 |
20200308153 | PROCESS FOR PREPARING ANTIHELMINTIC 4-AMINO-QUINOLINE-3-CARBOXAMIDE DERIVATIVES | 2020-10-01 |
20200308154 | KU INHIBITORS AND THEIR USE | 2020-10-01 |
20200308155 | Substituted Ureas and Methods of Making and Using Same | 2020-10-01 |
20200308156 | BIGUANIDE DERIVATIVES AND THEIR REARRANGEMENT PRODUCTS FOR USE IN THE TREATMENT OF CANCER | 2020-10-01 |
20200308157 | ISOXAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | 2020-10-01 |
20200308158 | BEZOXAZINE DERIVATIVES USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2020-10-01 |
20200308159 | SPHINGOSINE KINASE INHIBITOR AMIDOXIME PRODRUGS | 2020-10-01 |
20200308160 | TRPV4 ANTAGONIST | 2020-10-01 |
20200308161 | OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS | 2020-10-01 |
20200308162 | DRUGS AND COMPOSITIONS FOR OCULAR DELIVERY | 2020-10-01 |
20200308163 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING | 2020-10-01 |
20200308164 | 5-[2-(PYRIDIN-2-YLAMINO)-1,3-THIAZOL-5-YL]-2,3-DIHYDRO-1 H-ISOINDOL-1 -ONE DERIVATIVES AND THEIR USE AS DUAL INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE DELTA & GAMMA | 2020-10-01 |
20200308165 | Compounds as Ras Inhibitors and Use Thereof | 2020-10-01 |
20200308166 | BACE1 INHIBITORS | 2020-10-01 |
20200308167 | COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME | 2020-10-01 |
20200308168 | FLUOROPHENYL SUBSTITUTED MUSCARINIC RECEPTOR LIGANDS WITH SELECTIVITY FOR M3 OVER M2 | 2020-10-01 |
20200308169 | HETEROCYCLIC COMPOUNDS AS ANTIBACTERIALS | 2020-10-01 |
20200308170 | KRAS G12C INHIBITORS | 2020-10-01 |
20200308171 | BIFUNCTIONAL INHIBITORS WITH EGFR HAVING A E3 UBIQUITIN LIGASE MOIETY | 2020-10-01 |
20200308172 | SUBSTITUTED INDOLE COMPOUNDS USEFUL AS TLR INHIBITORS | 2020-10-01 |
20200308173 | INHIBITORS OF KINASE NETWORKS AND USES THEREOF | 2020-10-01 |
20200308174 | NOVEL HDAC6 INHIBITORS, WITH IMPROVED SOLUBILITY AND THEIR USES | 2020-10-01 |
20200308175 | TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A PYRIDINE OR PYRAZINE MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR | 2020-10-01 |
20200308176 | CO-CRYSTALS OF NEFLAMAPIMOD (VX-745) | 2020-10-01 |
20200308177 | Oxy-fluoropiperidine Derivative as Kinase Inhibitor | 2020-10-01 |
20200308178 | SOLID FORMS OF A COMPOUND OF HBV CORE PROTEIN ALLOSTERIC MODIFIER | 2020-10-01 |
20200308179 | DNA Polymerase IIIC Inhibitors and Use Thereof | 2020-10-01 |
20200308180 | DNA Polymerase IIIC Inhibitors and Use Thereof | 2020-10-01 |
20200308181 | DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE | 2020-10-01 |
20200308182 | CRYPTATE COMPOUNDS | 2020-10-01 |
20200308183 | CRYPTATE COMPOUNDS | 2020-10-01 |
20200308184 | TETRAPYRROLIC CONJUGATES AND USES THEREOF FOR IMAGING | 2020-10-01 |
20200308185 | NOVEL MORPHINANS USEFUL FOR TREATING MEDICAL DISORDERS | 2020-10-01 |
20200308186 | EPOXY COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT OBTAINED BY CURING CURABLE COMPOSITION | 2020-10-01 |
20200308187 | SALTS OF 4-AMINO-N-(1-((3-CHLORO-2-FLUOROPHENYL)AMINO)-6-METHYLISOQUINOLIN- -5-YL)THIENO[3,2-D]PYRIMIDINE-7-CARBOXAMIDE, AND CRYSTALLINE FORMS THEREOF | 2020-10-01 |
20200308188 | THIENO[3,2-D]PYRIMIDINE DERIVATIVE COMPOUND HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASE | 2020-10-01 |
20200308189 | FUSED TRIAZOLE AGONISTS OF THE APJ RECEPTOR | 2020-10-01 |
20200308190 | HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2020-10-01 |
20200308191 | CRYSTALLINE FORM OF LORLATINIB FREE BASE HYDRATE | 2020-10-01 |
20200308192 | NOVEL THIAZOLO[5,4-D]PYRIMIDINE DERIVATIVES AS INVERSE AGONISTS OF A2A ADENOSINE RECEPTORS | 2020-10-01 |
20200308193 | APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF | 2020-10-01 |
20200308194 | PROCESS FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE | 2020-10-01 |
20200308195 | DIAZAINDOLE COMPOUNDS | 2020-10-01 |
20200308196 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2020-10-01 |
20200308197 | SYNTHESIS OF BORONATE ESTER DERIVATIVES AND USES THEREOF | 2020-10-01 |
20200308198 | PROTEASOME ACTIVITY ENHANCING COMPOUNDS | 2020-10-01 |
20200308199 | METHOD OF PRODUCING A METHYLSILICIC ACID HYDROGEL WITH PROPERTIES OF SUPRAMOLECULAR STRUCTURES, AND A HYDROGEL PRODUCED USING THIS METHOD | 2020-10-01 |
20200308200 | CELL-PENETRATING, GUANIDINIUM-RICH OLIGOPHOSPHOTRIESTERS FOR DRUG AND PROBE DELIVERY | 2020-10-01 |
20200308201 | COMPOSITION AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | 2020-10-01 |
20200308202 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING ORGANOMETALLIC COMPOUND | 2020-10-01 |
20200308203 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | 2020-10-01 |
20200308204 | Organic electroluminescent materials and devices | 2020-10-01 |
20200308205 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | 2020-10-01 |
20200308206 | SYNTHESIS AND USE OF OXA-SPIRODIPHOSPHINE LIGAND | 2020-10-01 |
20200308207 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | 2020-10-01 |
20200308208 | DINUCLEAR PLATINUM(II) COMPOUNDS AND METHODS OF USE THEREOF | 2020-10-01 |
20200308209 | ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS | 2020-10-01 |
20200308210 | METHODS FOR PREPARING METAL CARBOXYLATES IN ONE-POT REACTION | 2020-10-01 |
20200308211 | PROCESS FOR PURIFYING SIALYLATED OLIGOSACCHARIDES | 2020-10-01 |
20200308212 | PREPARATION COMPRISING ARABINOXYLO-OLIGOSACCHARIDES | 2020-10-01 |
20200308213 | SMALL MOLECULE INHIBITORS OF GALECTIN-3 | 2020-10-01 |
20200308214 | NUCLEOSIDE PHOSPHATE COMPOUND AND PREPARATION METHOD AND USE THEREOF | 2020-10-01 |
20200308215 | Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT | 2020-10-01 |
20200308216 | PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY | 2020-10-01 |
20200308217 | PROCESS FOR THE PURIFICATION OF METHYLCOBALAMIN | 2020-10-01 |
20200308218 | PROCESS FOR PURIFYING LIRAGLUTIDE | 2020-10-01 |
20200308219 | COMPOSITIONS CONTAINING HC-HA/PTX3 COMPLEXES AND METHODS OF USE THEREOF | 2020-10-01 |
20200308220 | AROMATIC-CATIONIC PEPTIDES CONJUGATED TO ANTIOXIDANTS AND THEIR USE IN TREATING COMPLEX REGIONAL PAIN SYNDROME | 2020-10-01 |
20200308221 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | 2020-10-01 |
20200308222 | ANTIMICROBIAL TETRAPEPTIDES | 2020-10-01 |
20200308223 | COMPOSITE POLYPEPTIDE HAVING A METAL BINDING MOTIF AND MOLECULAR CONSTRUCT COMPRISING THE SAME | 2020-10-01 |
20200308224 | DEPDC1-DERIVED PEPTIDE AND VACCINE CONTAINING SAME | 2020-10-01 |
20200308225 | NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS | 2020-10-01 |
20200308226 | NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS | 2020-10-01 |
20200308227 | NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS | 2020-10-01 |
20200308228 | PEPTIDE INHIBITORS OF HCV NS3/4A PROTEASE COMPRISING NON-PROTEINOGENIC AMINO RESIDUES | 2020-10-01 |
20200308229 | NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTS | 2020-10-01 |
20200308230 | Peptidic Modulators of Quorum Sensing in Staphylococcus Epidermidis | 2020-10-01 |
20200308231 | SOLUTION-PHASE AFFINITY SELECTION OF INHIBITORS FROM COMBINATORIAL PEPTIDE LIBRARIES | 2020-10-01 |
20200308232 | CORONAVIRUSES EPITOPE-BASED VACCINES | 2020-10-01 |
20200308233 | TRUNCATED ROTAVIRUS VP4 PROTEIN AND APPLICATION THEREOF | 2020-10-01 |
20200308234 | CHIMERIC ANTIGEN RECEPTOR (CAR) MODULATION | 2020-10-01 |